X-linked agammaglobulinemia (XLA) is a rare primary humoral immunodeficiency syndrome characterized by agammaglobulinemia, recurrent infections and bronchiectasis. Despite the association with end-stage bronchiectasis, the literature on XLA and lung transplantation is extremely limited. We report a series of 6 XLA patients with bronchiectasis who underwent lung transplantation. Short-term outcomes were excellent however long-term outcomes were disappointing with a high incidence of pulmonary sepsis and chronic lung allograft dysfunction (CLAD). This case series examines six patients with X-linked agammaglobulinemia and tracks their post-lung transplant course to highlight the challenges of immunosuppression and infection as well as chronic lung allograft dysfunction in these patients.
CITATION STYLE
Barnes, S., Kotecha, S., Douglass, J. A., Paul, E., Hore-Lacey, F., Stirling, R., … Westall, G. P. (2015). Evolving practice: X-linked agammaglobulinemia and lung transplantation. American Journal of Transplantation, 15(4), 1110–1113. https://doi.org/10.1111/ajt.13084
Mendeley helps you to discover research relevant for your work.